Odenville Drugs Logo Refill Now

Get Healthy!

  • Posted December 14, 2024

Active Monitoring May Be a Safe Treatment Option for Many Women with DCIS Breast Cancer, New Study Suggests

In a new study, women with low-risk DCIS breast cancer who underwent active monitoring had similar recurrence rates as women who underwent surgery to remove their cancer.

Health News is provided as a service to Odenville Drugs site users by HealthDay. Odenville Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2024 HealthDay All Rights Reserved.